These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10417682)

  • 21. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
    Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
    Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
    Lewy-Trenda I; Wierzchniewska-Ławska A
    Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma.
    Sack MJ; Astengo-Osuna C; Lin BT; Battifora H; LiVolsi VA
    Mod Pathol; 1997 Jul; 10(7):668-74. PubMed ID: 9237176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bauhinia purpurea (BPA) binding to normal and neoplastic thyroid glands.
    Sarker AB; Akagi T; Teramoto N; Nose S; Yoshino T; Kondo E
    Pathol Res Pract; 1994 Nov; 190(11):1005-11. PubMed ID: 7746733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of c-erbB-2 oncoprotein in human thyroid tumours.
    Utrilla JC; Martín-Lacave I; San Martín MV; Fernández-Santos JM; Galera-Davidson H
    Histopathology; 1999 Jan; 34(1):60-5. PubMed ID: 9934586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy.
    Nelson KK; Gattuso P; Xu X; Prinz RA
    Surgery; 2010 Oct; 148(4):654-60; discussion 660. PubMed ID: 20797751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
    Branet F; Caron P; Camallières M; Selves J; Brousset P
    Bull Cancer; 1996 Mar; 83(3):213-7. PubMed ID: 8695923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma.
    Dobashi Y; Sakamoto A; Sugimura H; Mernyei M; Mori M; Oyama T; Machinami R
    Am J Surg Pathol; 1993 Apr; 17(4):375-81. PubMed ID: 7684202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
    Dasović-Knezević M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland JM
    Mod Pathol; 1989 Nov; 2(6):610-7. PubMed ID: 2587568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of FB21 as a marker of glomerular endothelial cell injury.
    Kawasaki Y
    Fukushima J Med Sci; 2006 Dec; 52(2):35-43. PubMed ID: 17427754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma.
    Chandan VS; Faquin WC; Wilbur DC; Khurana KK
    Cancer; 2006 Oct; 108(5):331-6. PubMed ID: 16944537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunocytochemical demonstration of melanotransferrin (p97) in thyroid tumors of follicular cell origin.
    Barresi G; Tuccari G
    Pathology; 1994 Apr; 26(2):127-9. PubMed ID: 8090582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leu-7 immunoreactivity in cytologic specimens of thyroid lesions, with emphasis on follicular neoplasms.
    Ostrowski ML; Brown RW; Wheeler TM; Green LK; Schaffner DL
    Diagn Cytopathol; 1995 Jun; 12(4):297-302. PubMed ID: 7544717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.
    Shingu K; Fujimori M; Ito K; Hama Y; Kasuga Y; Kobayashi S; Itoh N; Amano J
    Endocr J; 1998 Feb; 45(1):35-43. PubMed ID: 9625444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of estrogen receptors in paraffin sections of human thyroid tissues.
    Hiasa Y; Nishioka H; Kitahori Y; Yane K; Nakaoka S; Ohshima M; Konishi N; Nishii K; Kitamura M; Sugimura M
    Oncology; 1991; 48(5):421-4. PubMed ID: 1745491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.